Indirect-acting cholinomemetics Flashcards
Indirect-acting cholinomimetics
- mechanisms of action = inhibiting AChE reversibly or irreversibly –> increase of concentration of ACh
- Reversible inhibitors are used in therapeutics
- irreversible inhibitors are used as insecticides (poisoning)
Edrophonium
- Short-acting
- USES:
–> Diagnosis of MG: if given Edrophonium, the patient will see dramatic improvement of symtpoms of MG, but not seen in other disorders (cholinergic crisis)
Neostigmine or Pyridostigmine
- Quarternary amines (NO CNS ENTRY)
- Intermediate-acting
- USES:
–> Used in the treatment of Myasthenia gravis (MG) because the drug acts peripherally
–> Neostigmine is pregerred in the treatment of paralytic ileus and urinary retention (make sure there is NO OBSTRUCTION)
Physostigmine
- tertiary amine –> ENTERS CNS
- intermediate-acting
- USES:
–> used in the treatment of glaucoma (open canal of schlemm and allow better drainage of aqueous humor inorder to releave intraocular pressure)
–> Antidote in atropine overdose
Donepezil (tacrine)
- lipid-soluble (CNS ENTRY)
- USES:
–> treatment of alzheimer disease (AChE Inhibitors are used to increase concentration of cholinergic NT in the CNS)
Organophosphates
- IRREVERSIBLE INHIBITORS of AChE
- LIPID-SOLUBLE, LONG ACTING
- USES:
–> INSECTICIDES (malathion, parathion
–> NERVE GASES
Symtpoms of AChE inhibitor intoxication
- D = DIARRHEA (GI PANS activity = increased secretion/contraction of GI smooth muscles)
- U = uncontroled URINATION (contraction of detrusor)
- M = MIOSIS (constiction of sphincter in eye)
- B = BRONCHIOLAR constriction (lungs)
- B = BRADYCARDIA, decreased contracitlity (heart)
- E = EXCITEMENT, convulsions, coma (CNS)
- L = LACRIMATION (glands)
- S = SWEATING (sweat glands)
- S = SALVATION (saliva glands)
**OVERACTIVITY OF ACETYLCHOLINE IN SYNAPSE**
Management of AChE inhibitor intoxication
- Supportive measures = terminate exposure, airway maintanence, oxygen delivery, treatment of shock, anti-convulsion therapy
- ATROPINE = antagonize the actions of muscarinic receptor sites
–> Relieves increased tracheobronchial and salivary secretions, bonchoconstriction, bradycardia, peripheral ganglionic and central actions of anti-AChE
- Reactivation of AChE via PRALIDOXIM (2-PAM)
–>function by dephosphorylating AChE leaving the function compound